Rituximab Sc and Iv Plus Chop Show Similar Efficacy and Safety in the Randomised Mabease Study in First-Line DLBCL
Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_46
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Wiley